COVID-19 in rheumatic disease patients on immunosuppressive agents
Sign Up to like & getrecommendations! Published in 2020 at "Seminars in Arthritis and Rheumatism"
DOI: 10.1016/j.semarthrit.2020.05.010
Abstract: Abstract Objective To analyze clinical characteristics and outcome of COVID-19 patients with underlying rheumatic diseases (RD) on immunosuppressive agents. Method A case series of COVID-19 patients with RD on disease modifying anti-rheumatic drugs (DMARDs) were… read more here.
Keywords: covid rheumatic; rheumatic disease; disease; immunosuppressive agents ... See more keywords
Syndemics & syndemogenesis in COVID-19 and rheumatic and musculoskeletal diseases: old challenges, new era.
Sign Up to like & getrecommendations! Published in 2021 at "Rheumatology"
DOI: 10.1093/rheumatology/keaa840
Abstract: People with rheumatic and musculoskeletal diseases (RMDs) are facing several challenges during the COVID-19 pandemic, such as poor access to regular health services and drug shortages, particularly in developing countries. COVID-19 represents a syndemic, synergistic… read more here.
Keywords: covid rheumatic; syndemogenesis covid; covid pandemic; syndemics syndemogenesis ... See more keywords